NCT05947994View on ClinicalTrials.gov

Elucidate Outcomes of Elective High-grade/Total Occlusion Intracranial Arteries Using Low-profile Self-expanding Stent

NACompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

April 20, 2024

Conditions
Intracranial AtherosclerosisStent StenosisIschemic Stroke
Interventions
PROCEDURE

Intracranial stenting with Credo® stent

Symptomatic ischemic stroke patients were treated with Credo® Stent

Trial Locations (1)

900000

Can Tho Stroke International Service General Hospital, Can Tho

Sponsors

Collaborators (1)

Acandis GmbH
All Listed Sponsors
collaborator

Acandis GmbH

INDUSTRY

lead

Can Tho Stroke International Services Hospital

OTHER

NCT05947994 - Elucidate Outcomes of Elective High-grade/Total Occlusion Intracranial Arteries Using Low-profile Self-expanding Stent | Biotech Hunter | Biotech Hunter